Global Flow Cytometry Market Size & Trends Report Segmented by Product (Instruments, Reagents & Consumables, Software, Accessories), Technology (Cell-based, Bead-based), Application (Research, Clinical, Industrial), End-user & Regional Forecast to 2030
The global flow cytometry market is expected to witness a CAGR of ~9% during the forecast period. High incidence and prevalence of HIV/AIDS and cancer, growing focus on immunology and immuno-oncology research, advent of AI platforms in flow cytometry workflows, increase in R&D investment to develop multicolor assays and advanced reagents are some of the key factors driving the market growth. However, higher costs of flow cytometry products is a major constraint for the growth of the flow cytometry market. To learn more about the research report, download a sample report.
Report Overview
Flow cytometry is a technique used to detect and measure physical and chemical characteristics of a population of cells or particles usually suspended in a fluid using a laser beam. The technique helps in understanding the structure and composition of cells for chromosome analysis, cancer diagnosis, protein expression, diagnosis of diseases and hematological malignancies.
Most common types of flow cytometry-based proliferation assays are cell-based and bead-based assays. Today, cell-based assays are used in more than half of all high-throughput drug screenings for target validation and ADMET (absorption, distribution, metabolism, elimination and toxicity) in the early stage of drug discovery due to its enhanced accuracy and portability. On the other hand, Bead-based assays are used to study infectious diseases. Owing to advancements in molecular engineering and monoclonal antibody production, the demand for these assays is expected to rise in the coming years.
Furthermore, improvements in fluorescent dyes, advancements in multicolor flow cytometry (which finds extensive applications in new drug development), development of advanced reagents and AI based software platforms and algorithms are fueling the growth of the market.
To learn more about this report, download the PDF brochure
Rise in chronic disease increases flow cytometry utilization
Rising prevalence of chronic diseases such as cancer, HIV/AIDS, hematological malignancies and others is fueling the growth of the global flow cytometry market. Flow cytometry is considered an efficient tool for clinically diagnosing these diseases. The developments in immunology and other areas of cancer research have immensely contributed to the use of flow cytometry. Growing preference by health specialists to use allergenic and autologous stem cell therapies instead of radiation and chemotherapies is another key factor driving the market. Rising R&D investment by biotech and biopharma companies to introduce new technologies is also expected to propel the global flow cytometry market. For instance,
- In May 2024, Agilent Technologies introduced the NovoCyte Opteon Spectral Flow Cytometer, a system comprising 3-5 lasers, 73 detectors, enabling high-dimensional analysis of over 40 cellular markers with user-friendly software for diverse research applications
- In March 2024, Beckman Coulter Life Sciences launched the CytoFLEX Nano Flow Cytometer, an advanced platform optimized for high-sensitivity detection and characterization of extracellular vesicles and nanoparticles, providing researchers with enhanced resolution and analytical capabilities
Growing adoption of flow cytometry in stem cell research
Flow cytometry and cell sorting are critical tools in stem cell research. Recent advances in flow cytometric hardware, reagents and software have synergized to permit the stem cell biologist to better identify and isolating rare cells based on their immunofluorescence and light scattering characteristics. In contrast to other methods, such as Western blot and cellular imaging, multicolor flow cytometry enables researchers to interrogate heterogeneous cell populations and analyze their subpopulations. By using multiple fluorescent-labelled antibodies, researchers can obtain robust data and population-based statistics on differentiating stem cell cultures and isolate stem cells and their derivatives from primary tissue and diverse in-vitro populations.
There has been extraordinary growth in stem cell research and related applied clinical practices. The current flow cytometry applications in clinical research include emphasizing immunophenotyping, enumerating reticulocyte, reticulated platelet, multiple drug resistance assays, cell function assays and apoptosis. During pandemic, stem cell-based therapies were also recommended to manage or treat COVID-19 infections. The growing market penetration in stem cell research, adoption of recombinant DNA technology for antibody production, and evolution of tandem flow cytometry technologies is expected to open growth opportunities in the market.
“Flow Cytometry is turning researchers into molecular detectives and helping them to delve into the depths of diseases. It allows researchers and scientists to probe the more complex and transient cellular changes that underpin the course of disease and responses to treatment, helping them better select the right drug target”.
- Senior Director, Data Sciences & Quantitative Biology, Pharmaceutical & Biotechnology Company, United States
North America leads in terms of adoption of the flow cytometry market
North America dominates the global flow cytometry market, followed by Europe. Growing research activities, well-established infrastructure, rising drug discovery and development and presence of leading pharmaceutical companies in this region are some of the key factors driving the market growth.
In Asia Pacific, emerging economies like India and China are anticipated to grow significantly over the forecast period. Improving research infrastructure, adopting the latest technology and government support for establishing the pharmaceutical industry is likely to fuel the demand for the flow cytometry market in this region.
To learn more about this report, download the PDF brochure
Competitive Landscape Analysis
The global flow cytometry market is marked by the presence of established and emerging market players such as Becton, Dickinson and Company; Danaher Corporation; Thermo Fisher Scientific, Inc.; DiaSorin S.p.A; Agilent Technologies, Inc.; Sony Group Corporation; Bio-Rad Laboratories, Inc.; Miltenyi Biotec GmbH; Apogee Flow Systems Ltd.; BioMérieux S.A.; Cytek Biosciences, Inc.; NanoCellect Biomedical, Inc., among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.
Report Scope
| Report Metric | Details |
| Base Year Considered | 2024 |
| Historical Data | 2023 – 2024 |
| Forecast Period | 2025 – 2030 |
| Growth Rate | ~9% |
| Market Drivers |
|
| Attractive Opportunities |
|
| Segment Scope | Product, Technology, Application, and End-user |
| Regional Scope |
|
| Key Companies Mapped | Becton, Dickinson and Company; Danaher Corporation; Thermo Fisher Scientific, Inc.; DiaSorin S.p.A; Agilent Technologies, Inc.; Sony Group Corporation; Bio-Rad Laboratories, Inc.; Miltenyi Biotec GmbH; Apogee Flow Systems Ltd.; BioMérieux S.A.; Cytek Biosciences, Inc.; NanoCellect Biomedical, Inc., among others |
| Report Highlights | Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis |
Global Flow Cytometry Market Segmentation
This report by Medi-Tech Insights provides the size of the global flow cytometry market at the regional- and country-level from 2023 to 2030. The report further segments the market based on product, technology, application, and end-user.
Market Size & Forecast (2023-2030), By Product, USD Million
- Instruments
- Cell Sorters
- Cell Analyzers
- Reagents & Consumables
- Software
- Accessories
Market Size & Forecast (2023-2030), By Technology, USD Million
- Cell-based
- Bead-based
Market Size & Forecast (2023-2030), By Application, USD Million
- Research
- Clinical
- Industrial
Market Size & Forecast (2023-2030), By End-user, USD Million
- Hospitals
- Academic & Research Institutes
- Biopharma Companies
- Clinical Labs
- Others
Market Size & Forecast (2023-2030), By Region, USD Million
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
Key Strategic Questions Addressed
- What is the market size & forecast of the flow cytometry market?
- What are historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the flow cytometry market?
- What are the key trends defining the market?
- What are the major factors impacting the market?
- What are the opportunities prevailing in the market?
- Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
- Who are the major players operating in the market?
- What are the key strategies adopted by players?
- Introduction
- Introduction
- Market Scope
- Market Definition
- Segments Covered
- Regional Segmentation
- Research Timeframe
- Currency Considered
- Study Limitations
- Stakeholders
- List of Abbreviations
- Key Conferences and Events (2025-2026)
- Research Methodology
- Secondary Research
- Primary Research
- Market Estimation
- Bottom-Up Approach
- Top-Down Approach
- Market Forecasting
- Executive Summary
- Flow Cytometry Market Snapshot (2025-2030)
- Segment Overview
- Regional Snapshot
- Competitive Insights
- Market Overview
- Market Dynamics
- Drivers
- Growing use in cancer and immunology research
- Rising demand in stem cell and regenerative medicine
- Advances in multicolor and spectral flow cytometry
- Increasing adoption in drug discovery and development
- High prevalence of chronic and infectious diseases
- Rising R&D investments by biotech and pharma companies
- Restraints
- High cost of instruments and maintenance
- Complex data analysis and the need for skilled personnel
- Stringent regulatory and standardization requirements for clinical use
- Opportunities
- Growth of microfluidic and portable flow cytometry devices
- Development of spectral and full-spectrum cytometry
- Rising clinical applications in CAR-T and gene therapies
- Expansion into emerging markets
- Key Market Trends
- AI and machine learning for automated data analysis
- Launch of nanoparticle-focused cytometers
- Novel antibody reagents improving disease detection
- Unmet Market Needs
- Industry Speaks
- Drivers
- Market Dynamics
- Global Flow Cytometry Market Size & Forecast (2023-2030), By Product, USD Million
- Introduction
- Instruments
- Cell Analyzer
- Cell Sorter
- Reagents & Consumables
- Software
- Accessories
- Global Flow Cytometry Market Size & Forecast (2023-2030), By Technology, USD Million
- Introduction
- Cell-based
- Bead-based
- Global Flow Cytometry Market Size & Forecast (2023-2030), By Application, USD Million
- Introduction
- Research
- Clinical
- Industrial
- Global Flow Cytometry Market Size & Forecast (2023-2030), By End-user, USD Million
- Introduction
- Hospitals
- Academic & Research Institutes
- Biopharma Companies
- Clinical Labs
- Others
- Global Flow Cytometry Market Size & Forecast (2023-2030), By Region, USD Million
- Introduction
- North America Flow Cytometry Market Size & Forecast (2023-2030), By Country, USD Million
- US
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Canada
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- US
- Europe Flow Cytometry Market Size & Forecast (2023-2030), By Country, USD Million
- UK
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Germany
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- France
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Italy
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Spain
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Rest of Europe
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- UK
- Asia Pacific (APAC) Flow Cytometry Market Size & Forecast (2023-2030), By Country, USD Million
- China
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Japan
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- India
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Rest of Asia Pacific
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- China
- Latin America (LATAM) Flow Cytometry Market Size & Forecast (2023-2030), USD Million
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Middle East & Africa (MEA) Flow Cytometry Market Size & Forecast (2023-2030), USD Million
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Competitive Landscape
- Key Players and their Competitive Positioning
- Key Player Comparison
- Segment-wise Player Mapping
- Market Share Analysis (2024)
- Company Categorization Matrix
- Dominants/Leaders
- New Entrants
- Emerging Players
- Innovative Players
- Key Strategies Assessment, By Player (2022-2025)
- New Product Launches
- Partnerships, Agreements, & Collaborations
- Mergers & Acquisitions
- Geographic Expansion
- Key Players and their Competitive Positioning
- Company Profiles*
(Business Overview, Financial Performance**, Products Offered, Recent Developments)
- Becton, Dickinson and Company
- Danaher Corporation
- Thermo Fisher Scientific, Inc
- DiaSorin S.p.A
- Agilent Technologies, Inc.
- Sony Group Corporation
- Bio-Rad Laboratories, Inc.
- Miltenyi Biotec GmbH
- Apogee Flow Systems Ltd.
- BioMérieux S.A
- Other Prominent Players
Note: *Indicative list
**For listed companies
The study has been compiled based on extensive primary and secondary research.
Secondary Research (Indicative List)
Primary Research
To validate research findings (market size & forecasts, market segmentation, market dynamics, competitive landscape, key industry trends, etc.), extensive primary interviews were conducted with both supply and demand-side stakeholders.
Supply Side Stakeholders:
- Senior Management Level: CEOs, Presidents, Vice-Presidents, Directors, Chief Technology Officers, Chief Commercial Officers
- Mid-Management Level: Product Managers, Sales Managers, Brand Managers, R&D Managers, Business Development Managers, Consultants
Demand Side Stakeholders:
- Stakeholders from Hospitals, Biopharma Companies, and Others
Breakdown of Primary Interviews
Market Size Estimation
Both ‘Top-Down & Bottom-Up Approaches’ were used to derive market size estimates and forecasts
Data Triangulation
Research findings derived through secondary sources & internal analysis was validated with Primary Interviews, Internal Knowledge Repository and Company’s Sales Data
